S 3257
117th Congress
Senate
Crime and Law Enforcement
A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.
Introduced: November 18, 2021
Introduced by:
Shaheen, Jeanne
Democratic
· New Hampshire
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 18, 2021
Read twice and referred to the Committee on the Judiciary.
Nov 18, 2021
Introduced in Senate
Plain-English summary
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.
What's happening now
Read twice and referred to the Committee on the Judiciary.
Committees of jurisdiction
1
Cosponsors
1